Simultaneous Electrochemical Detection of NGF and proNGF Under Native Conditions Using Molecularly Imprinted Polymers: Toward Point‐of‐Care Diagnosis of Alzheimer's Disease
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Giulia Siciliano und 12 weiteren Autor:innen. Beteiligte Einrichtung: CNR NANOTEC - Institute of Nanotechnology, Lecce, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Nerve Growth Factor, Molecularly Imprinted Polymers, Electrochemical Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BIO-TEST - Circulating biomarkers and innovative device, ALT-CAN - BaC HEAL ITALIA PNRR Mission 4 - Component 2Mission 4 - Component 2. Progetto, TITAN: Nano- tecnologie per l'ImmunoTerapia dei Tu0mori - FESR Programme PON "Ricerca e Innovazione".
Themen: Demenz
Abstract (Originalsprache)
In the brain, proNGF, the NGF precursor, is in a homeostatic equilibrium with its processing product, mature NGF. Dysregulation of the NGF/proNGF ratio has been associated with neurodegeneration in Alzheimer's disease (AD), positioning these neurotrophins as promising diagnostic biomarkers. Yet, their clinical validation as biomarkers has been hindered by the lack of analytical methods capable of discriminating and quantifying both isoforms under native conditions. Here, we introduce a dual electrochemical sensor based on Molecularly Imprinted Polymers (MIPs) that enables the simultaneous, selective, and label‐free quantification of NGF and proNGF. The sensors were fabricated via electropolymerization of o ‐phenylenediamine on platinum microelectrodes, yielding highly specific recognition sites for each isoform. The MIP‐based platform demonstrates remarkable selectivity, reproducibility, and isoform discrimination, achieving picomolar detection limits even for NGF, which is typically present at low concentration in cerebrospinal fluid (CSF). Validated on clinical CSF samples from AD and control patients, this system successfully quantifies both NGF and proNGF without antibodies or sample denaturation. To the best of our knowledge, this represents the first quantitative and simultaneous detection of NGF and proNGF under native conditions. This technology paves the way toward cost‐effective, high‐throughput, and point‐of‐care diagnostics for Alzheimer's and other neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CNR NANOTEC - Institute of Nanotechnology, Lecce, Italy.
- TecnoMedPuglia, Tecnopolo Per La Medicina Di Precisione (Biotech Lecce Hub), c/o Campus Ecotekne, Lecce, Italy.
- Department of Experimental Medicine, University of Salento, Lecce, Italy.
- Department of Innovation Engineering, University of Salento, Lecce, Italy.
- European Brain Research Institute (EBRI) Rita Levi-Montalcini, Lecce, Italy.
- Center For Neurodegenerative Diseases and the Aging Brain, Department of Clinical Research in Neurology, University of Bari "Aldo Moro"; "Pia Fondazione Cardinale G. Panico", Tricase, Lecce, Italy, Lecce, Italy.
Förderung
- BIO-TEST - Circulating biomarkers and innovative device
- ALT-CAN - BaC HEAL ITALIA PNRR Mission 4 - Component 2Mission 4 - Component 2. Progetto
- TITAN: Nano- tecnologie per l'ImmunoTerapia dei Tu0mori - FESR Programme PON "Ricerca e Innovazione"
- "Tecnopolo per la medicina di precisione" (TecnoMed Puglia)
- Biotecnologia, Bioinformatica e sviluppo Farmaceutico. Piano operativo Salute: FSC 2014-2020.Traiettoria 4, Azione 4.1 - Cofinanziato dalla Regione Puglia; Fon…
Zitieren
APA
Siciliano, G., Cillis, A., Clabassi, E., Ferrara, F., Chiriacò, M. S., Turco, A., Loiola, C., Zecca, C., Dell'Abate, M. T., Logroscino, G., Gigli, G., Malerba, F., & Primiceri, E. (2026). Simultaneous Electrochemical Detection of NGF and proNGF Under Native Conditions Using Molecularly Imprinted Polymers: Toward Point‐of‐Care Diagnosis of Alzheimer's Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71262
Vancouver
Siciliano G, Cillis A, Clabassi E, Ferrara F, Chiriacò MS, Turco A, et al. Simultaneous Electrochemical Detection of NGF and proNGF Under Native Conditions Using Molecularly Imprinted Polymers: Toward Point‐of‐Care Diagnosis of Alzheimer's Disease. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71262
BibTeX
@article{Siciliano2026,
author = {Siciliano, Giulia and Cillis, Alfredo De and Clabassi, Elena and Ferrara, Francesco and Chiriacò, Maria Serena and Turco, Antonio and Loiola, Clarissa and Zecca, Chiara and Dell'Abate, Maria Teresa and Logroscino, Giancarlo and Gigli, Giuseppe and Malerba, Francesca and Primiceri, Elisabetta},
title = {Simultaneous Electrochemical Detection of NGF and proNGF Under Native Conditions Using Molecularly Imprinted Polymers: Toward Point‐of‐Care Diagnosis of Alzheimer's Disease},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71262}
}
EUVIMED